TAXUS Stent

Related by string. Taxus stent * taxus . Taxus : yew Taxus . TAXUS Liberte stent . TAXUS Liberte . Boston Scientific Taxus . TAXUS Liberte Stent . Taxus Liberte . TAXUS Express / stenting . Stents . Stenting . stented . stents . STENT . stent : stents inserted . drug coated stents . drug coated stent . Endeavor stent . stent graft . definite stent thrombosis . Valiant Thoracic Stent Graft * *

Related by context. All words. (Click for frequent words.) 75 XIENCE V PROMUS Stent 74 Coronary Stent 74 TAXUS stent 74 Cypher Stent 73 XIENCE V stent 72 sirolimus eluting stent 72 CYPHER ® Stent 72 everolimus eluting stent 72 TAXUS Express Stent 72 sirolimus eluting stents 72 paclitaxel eluting stent 72 CYPHER Stent 71 TAXUS Liberte Stent 71 TAXUS 71 TAXUS Express 71 TAXUS TM 71 PROMUS 71 TAXUS Express2 70 XIENCE V Everolimus Eluting 70 TAXUS Liberte 70 ximelagatran 70 CYPHER R Sirolimus eluting 69 drug eluting coronary stents 69 binary restenosis 69 PROMUS Element 69 Sirolimus eluting Coronary Stent 69 mm Stent 69 Drug eluting stent 69 ARIXTRA 69 angiographic outcomes 69 TAXUS ® 68 Resolute DES 68 segment binary restenosis 68 Taxus Stent 68 drug eluting stent DES 68 Events MACE 68 TAXUS Liberte stent 68 paclitaxel eluting stents 68 CYPHER ® 68 Everolimus Eluting Coronary Stent 68 Eluting Coronary Stent System 68 pioglitazone HCl 68 Bare Metal Stent 68 Endeavor drug eluting 68 stent DES 68 NEVO 68 NEVO ™ 68 Anti Bacterial Envelope 68 eplerenone 67 irbesartan 67 neointimal hyperplasia 67 MitraClip 67 paclitaxel eluting 67 TAXUS Element Stent 67 CIMZIA ™ 67 Coronary Stent System 67 rFVIIa 67 drug eluting coronary stent 67 TAXUS Liberte Long 67 Valsartan 67 ARCOXIA 67 Sirolimus Eluting Coronary Stent 67 decitabine 67 sirolimus eluting 67 cinacalcet 67 PROMUS ® 67 NAVISTAR R 67 fluvastatin 67 CANCIDAS 67 XIENCE TM 67 XIENCE V 67 GP IIb IIIa inhibitors 67 CYPHER R Stent 67 Endeavor stent 67 AneuRx 67 Stent System 66 diameter stenosis 66 teriflunomide 66 zotarolimus 66 sipuleucel T 66 paclitaxel eluting coronary stent 66 events MACE 66 PROMUS TM 66 carotid artery stenting 66 carotid artery stenting CAS 66 target lesion revascularization 66 CIMZIA TM 66 Hycamtin ® 66 XIENCE 66 carotid stenting 66 Self Expanding Stent 66 MACCE 66 zotarolimus eluting stent 65 everolimus eluting stents 65 thrombus aspiration 65 Stent thrombosis 65 YERVOY 65 Cordis Cypher 65 plasma kallikrein inhibitor 65 Amrubicin 65 glycated hemoglobin levels 65 TAXUS Liberté stent 65 NEVO TM 65 ZoMaxx 65 Xience V 65 Atom Stent 65 DEFINITY ® 65 unstable angina pectoris 65 CRT Ds 65 ischemic cardiomyopathy 65 CYPHER ® Sirolimus eluting 65 active comparator 65 TAXUS R 65 sirolimus stent 65 ATACAND 65 nondiabetic patients 65 unfractionated heparin UFH 65 pioglitazone Actos 65 EverFlex 65 Target Lesion Revascularization TLR 65 Prospective Randomized 65 RE LY ® 65 primary patency 65 ULORIC 65 TAXUS IV 65 MADIT II 65 pegylated liposomal doxorubicin 65 posaconazole 65 Randomized Evaluation 65 Evicel 65 Patency 65 Nitinol Stent 65 thromboembolic events 65 candesartan cilexetil 65 oral diclofenac 65 CentriMag 65 Embolic Protection Device 65 receiving prophylactic anticoagulation 65 SPIRIT III 65 serum phosphorus 65 DAPT 65 Cypher Sirolimus 65 Acute Ischemic Stroke 65 oral FTY# 65 STRIDE PD 65 antiplatelet drugs 65 Candesartan 65 BARACLUDE ® 65 AVANDIA 64 Rivaroxaban 64 6R BH4 64 Paclitaxel Eluting Coronary Stent 64 romiplostim 64 Drug Eluting Stent 64 Drug Eluting Stents 64 valdecoxib 64 myocardial reperfusion 64 Hypotension 64 ZYVOX 64 MabCampath 64 NATRECOR ® 64 TAXUS VI 64 MitraClip device 64 Percutaneous Transluminal Coronary Angioplasty 64 epoetin alfa 64 TAXUS Element Paclitaxel Eluting 64 PROMUS R 64 clodronate 64 Embolic Protection System 64 Express2 TM paclitaxel eluting 64 rosuvastatin #mg 64 Taxus Liberte 64 BENICAR HCT 64 FASLODEX 64 Platinum Chromium Coronary Stent 64 ™ Everolimus Eluting 64 Tavocept 64 deep venous thromboses 64 Endeavor Drug Eluting 64 APTIVUS r 64 Pivotal Trial 64 antiplatelet agent 64 Vfend 64 fondaparinux 64 Sirolimus 64 stent thromboses 64 Bivalirudin 64 mycophenolate mofetil 64 β blockers 64 oxycodone CR 64 Bare Metal Stents 64 TAXUS Liberté 64 ezetimibe simvastatin 64 INTEGRILIN 64 chlorambucil 64 Glucophage XR 64 symptomatic VTE 64 Posaconazole 64 XIENCE V demonstrated 64 adalimumab 64 MERLIN TIMI 64 nicardipine 64 vildagliptin 64 olmesartan 64 paroxysmal AF 64 PEGylated interferon beta 1a 64 clopidogrel Plavix ® 64 Medtronic Endeavor 64 ischemic complications 64 dalteparin 64 Dasatinib 64 INC# 64 ACTEMRA TM 64 TM Drug Eluting 64 SPIRIT FIRST 64 thromboembolism 63 clopidogrel Plavix 63 platelet reactivity 63 RE LY 63 iodixanol 63 Lantus ® 63 HBeAg positive patients 63 aldosterone antagonists 63 pamidronate 63 Pemetrexed 63 Pivotal Clinical Trial 63 idraparinux 63 NYHA Class II 63 Pioglitazone 63 Azilect ® 63 Betaferon ® 63 saphenous vein grafts 63 Camptosar ® 63 Pegylated Liposomal Doxorubicin 63 R Paclitaxel Eluting 63 Cilostazol 63 tapentadol ER 63 gliclazide 63 drug eluting stents 63 arterial thromboembolic events 63 Trastuzumab 63 GORE TAG Device 63 Major Adverse Cardiac 63 COPAXONE R 63 PRADAXA 63 stent restenosis 63 definite stent thrombosis 63 liposomal doxorubicin 63 venous thromboembolic events 63 degarelix 63 Natalizumab 63 Xanafide 63 TRITON TIMI 63 fosamprenavir 63 sirolimus 63 QTc prolongation 63 morphometric vertebral fractures 63 CYPHER stent 63 perioperative mortality 63 reinfarction 63 RX ACCULINK 63 Losartan 63 Restenosis 63 Xelox 63 Navelbine ® 63 levosimendan 63 concurrent chemoradiation 63 cardiac resynchronisation therapy 63 ZOMIG R 63 EDEMA3 63 SYNERGY Stent 63 ReoPro 63 Platinum Chromium 63 thromboembolic complications 63 imipenem 63 V Everolimus Eluting Coronary 63 CYCLOSET 63 Atacand 63 PASI scores 63 PRECiSE 63 FOLPI 63 Diovan HCT 63 micafungin 63 Valiant Thoracic Stent Graft 63 OPCAB 63 GORE VIABAHN Endoprosthesis 63 colorectal liver metastases 63 TAXUS ATLAS 63 aripiprazole Abilify 63 PegIntron 63 lanthanum carbonate 63 ZD# [001] 63 standard chemotherapy regimen 63 Betaferon R 63 TREDAPTIVE 63 IIIa inhibitor 63 Telmisartan 63 tigecycline 63 antithrombotics 63 Emboli Capture Guidewire 63 thrombotic events 63 aspirin clopidogrel 63 Talent Abdominal 63 Carvedilol 63 cardiac resynchronization 63 AZT zidovudine Retrovir 63 aldosterone antagonist 63 MEVACOR 63 ibandronate 63 Fondaparinux 63 Mylotarg 63 QuadraSphere 63 #mg BID [001] 63 sustained virological response 63 SVR# 63 BeneFIX 63 certolizumab 63 LANTUS ® 63 Unfractionated Heparin 63 Xience Prime 63 ARB telmisartan 63 CYPHER R Sirolimus Eluting 63 LEUKINE 63 secondary efficacy endpoints 63 eluting stent 63 defibrillator CRT D 63 mechanical thrombectomy 63 lumbar spine BMD 63 CONTRAINDICATIONS 63 Moxifloxacin 63 primary percutaneous coronary 63 PLAVIX R 63 virologic response 63 nonrandomized 63 composite endpoint 63 TriActiv R 63 Elitek 63 REMICADE ® 63 bivalirudin 63 VAPRISOL 63 HeartMate R 63 Engerix B 63 PROMUS Element Stent 63 Procoralan 63 PEG INTRON 62 Liberte TM 62 ENDEAVOR IV 62 PROMACTA 62 ENDEAVOR II 62 carotid stent 62 DOXIL 62 deferiprone 62 Acute Myocardial Infarction AMI 62 Express2 62 Adhesion Barrier 62 biologic DMARD 62 NATRECOR R 62 Arixtra 62 peripheral vascular stent 62 Bucindolol 62 calcineurin inhibitors 62 briakinumab 62 NEUPOGEN 62 NeuroStar TMS Therapy 62 octreotide 62 Doxil ® 62 octreotide LAR 62 drug eluting stent 62 Drug Eluting Stent System 62 bezafibrate 62 Sandostatin LAR 62 Endoprosthesis 62 invasive candidiasis 62 TAXUS p value 62 adalimumab Humira 62 eptifibatide 62 TMC# r 62 serum phosphorous 62 gadobutrol 62 rilonacept 62 DU #b 62 uncoated stent 62 efficacy endpoint 62 Vimpat R 62 cediranib 62 plus dexamethasone 62 InterStim Therapy 62 evaluating tivozanib 62 XELOX 62 ALVESCO 62 coronary stenting 62 metastatic malignant 62 cerebrovascular events 62 TAXUS Element Stent System 62 ORENCIA ® 62 HBeAg negative patients 62 eluting coronary stent 62 OMNARIS Nasal Spray 62 Taxus Element 62 HeartMate XVE 62 DES implantation 62 carotid stents 62 Traficet EN 62 microbiological eradication 62 NovoSeven ® 62 COMFORT II 62 ARCALYST ® 62 thrombolytic agents 62 FIRMAGON 62 mcg QD 62 preventing restenosis 62 Endeavor Resolute 62 acute coronary syndromes ACS 62 Protelos 62 antiarrhythmic drug 62 brivaracetam 62 pegylated interferon alfa 2b 62 TM Everolimus Eluting 62 Resolute drug eluting 62 PERSEUS 62 eluting stents 62 MULTI LINK VISION 62 tocilizumab 62 ischemia driven 62 clevidipine 62 CORDAPTIVE 62 tirofiban 62 TAXUS Express2 Paclitaxel Eluting 62 patients undergoing percutaneous 62 Raptiva ® 62 metformin HCl 62 ularitide 62 cobiprostone 62 PRISTIQ 62 drug zotarolimus 62 paricalcitol 62 HBeAg seroconversion 62 saphenous vein graft 62 epoetin beta 62 INCB# [003] 62 docetaxel Taxotere ® 62 tipranavir r 62 SCIg 62 sunitinib malate 62 efalizumab 62 Ozurdex 62 Endurant 62 IFN beta 62 xanthine oxidase inhibitor 62 secondary efficacy endpoint 62 Kaplan Meier analysis 62 multivessel disease 62 ARIKACE 62 balloon kyphoplasty 62 INEGY 62 recurrent VTE 62 vertebral compression fractures 62 Angiox R 62 sitagliptin 62 MitraClip R 62 PEGINTRON TM 62 Percutaneous Coronary Intervention 62 LIALDA 62 BENICAR 62 Tacrolimus 62 Stenting 62 Hazard Ratio 62 FOLFOX4 62 bicalutamide 62 tolvaptan 62 MYCAMINE 62 ACTOS ® 62 Clolar ® 62 LVAS 62 FluCAM arm 62 recurrent GBM 62 revascularizations 62 lipid lowering agents 62 acute myocardial infarction AMI 62 carotid endarterectomy CEA 62 noninferior 62 Embolic Protection 62 Ventricular Assist Devices 62 brand ciclesonide HFA 62 Stent Thrombosis 62 terlipressin 62 Glatiramer Acetate 62 TYKERB 62 superficial femoral 62 tipranavir 62 reintervention 62 PROMUS Stent 62 GAMMAGARD 62 ENDEAVOR III 62 Abbokinase 62 bosentan 62 erlotinib Tarceva ® 62 Endeavor DES 62 Endurant Stent Graft 62 PICSO ® 62 zolmitriptan 62 CMV disease 62 metastatic RCC 62 mg kg dose 62 transfemoral 62 Aprotinin 62 GOUT 62 Heparin Bioactive Surface 62 elotuzumab 62 Express2 TM 62 pioglitazone 62 nesiritide 62 periprocedural 62 catheter occlusion 62 SYNTAX trial 62 Cardiac Resynchronization Therapy 62 Fludara 62 TPV r 62 percutaneous intervention 62 atherothrombotic events 62 Tumor Response 62 Aliskiren 61 Vidaza azacitidine 61 liposome injection 61 Increlex R 61 PROCRIT ® 61 systemic embolism 61 Fidaxomicin 61 wire OTW 61 Clinical Outcomes Utilizing Revascularization 61 thrombocytopenic 61 endoscopic remission 61 Cotavance 61 STELARA 61 lumiracoxib 61 Sitagliptin 61 Free Survival PFS 61 riociguat 61 Long Term Efficacy 61 relapsed MM 61 PTNS 61 IMPELLA 61 APTIVUS 61 bioabsorbable stent 61 rizatriptan 61 factor Xa 61 divalproex sodium 61 Cleviprex TM clevidipine 61 Reveal XT 61 Mg Usa 61 SEROQUEL R 61 doxorubicin docetaxel 61 IRESSA 61 stent BMS 61 ertapenem 61 Severe Sepsis 61 NOXAFIL 61 stent binary restenosis 61 ZOLINZA 61 hemodynamically significant 61 ranolazine 61 LEVAQUIN ® 61 trials RCTs 61 antiarrhythmic drugs 61 Neulasta ® 61 Acute Coronary Syndromes 61 glatiramer acetate 61 TORISEL 61 abacavir lamivudine 61 pulsatile flow 61 sorafenib Nexavar 61 adult chronic ITP 61 Kepivance 61 ICD implants 61 non valvular atrial 61 Drug Eluting 61 surrogate endpoint 61 Dapagliflozin 61 de novo lesions 61 CAELYX 61 azacitidine 61 oral rivaroxaban 61 lispro 61 Gliadel Wafer 61 Emboshield 61 RAPAFLO 61 enalapril 61 nephrotoxicity 61 percutaneous transluminal coronary angioplasty 61 PLAVIX 61 COZAAR 61 HepaSphere 61 lumbar spine bone 61 Non inferiority 61 Mycophenolate Mofetil 61 CIMZIA TM certolizumab pegol 61 Rasilez Tekturna 61 Patients Treated With 61 infusional 5-FU/LV 61 dose atorvastatin 61 angiographic restenosis 61 COPAXONE ® 61 Antihypertensive 61 vessel renarrowing 61 Acute Myocardial Infarction 61 interferon alfa 61 Navelbine 61 rt PA 61 intravesical therapy 61 Prograf ® 61 Fulvestrant 61 LEXIVA r 61 Taxol ® 61 p = NS 61 ipsilateral stroke 61 colesevelam HCl 61 ISENTRESS 61 Pharmacokinetic parameters 61 Vascular Wrap 61 oxymorphone ER 61 Degarelix 61 Custom NX R 61 Angiox 61 ABSORB trial 61 Eraxis 61 VADT 61 Teriflunomide 61 Aptivus ® 61 titrated glipizide 61 dabigatran etexilate 61 candesartan 61 CYPHER 61 Augment Injectable 61 coronary intervention 61 crizotinib PF # 61 VICTRELIS 61 TELIGEN 61 BAY #-# 61 Thrombectomy 61 GP IIb IIIa inhibitor 61 mg BID dose 61 Aprovel 61 XGEVA 61 Vascular Grafts 61 voriconazole 61 Bone Graft 61 EDARBI 61 INVEGA ® 61 GnRH agonist 61 Angiographic 61 APTIVUS R 61 Fibrin Pad 61 Coronary Artery Bypass Graft 61 Lantus R 61 Warfarin Coumadin 61 RoACTEMRA 61 myocardial infarction MI 61 EXJADE 61 NexStent 61 ACTEMRA 61 Vascugel 61 HuMax EGFr 61 bisoprolol 61 SilverHawk 61 oral Hycamtin 61 icatibant 61 coxib 61 beta blocker therapy 61 noninferiority 61 virologic failure 61 Ramipril 61 Talent Abdominal Stent Graft 61 alemtuzumab treated 61 salmeterol fluticasone 61 FOLFOX6 61 peginterferon alfa 2b 61 5 Fluorouracil 61 Pulse Oximeters 61 bendamustine 61 comparator arm 61 patients undergoing CABG 61 renal toxicity 61 THERMOCOOL R 61 MGd 61 Eluting Stent 61 Fludara ® 61 VIDAZA 61 piperacillin tazobactam 61 vinorelbine 61 prospective multicenter randomized 61 HSCT 61 edifoligide 61 LEVAQUIN 61 hsCRP levels 61 5-FU/LV 61 oral anticoagulant 61 Epoetin alfa 61 fibrinolytic 61 NLX P# 61 Medtronic Endeavor stent 61 placebo dexamethasone 61 angiotensin receptor blocker ARB 61 plus GP IIb 61 VNS Therapy TM 61 Micardis ® 61 platelet inhibitor 61 macrolide antibiotic 61 PROMUS Element Everolimus Eluting 61 prospectively defined 61 alicaforsen enema 61 Starlix 61 platelet aggregation inhibitor 61 atherothrombotic disease 61 lucinactant 61 ACE Inhibitors 61 anti arrhythmic drug 61 colorectal adenoma 61 bioabsorbable polymer 61 cardiac resynchronization therapy 61 rivaroxaban 61 Alkeran 61 Endarterectomy 61 sustained virologic response 61 complete cytogenetic response 61 fondaparinux sodium 61 stent thrombosis 61 refractory recurrent 61 thalidomide Thalomid 61 hematologic toxicity 61 Increlex ® 61 Newly Diagnosed Multiple Myeloma 61 pitavastatin 61 Cimzia TM 61 Long Lesion 61 Thrombin 61 PENNSAID 61 EVEREST II 61 lanreotide 61 glimepiride 61 stent implantation 61 ancrod 61 ID TLR 61 FACTIVE tablets 61 endoleaks 61 revascularization procedures 61 gefitinib Iressa 61 Lenalidomide 61 Subgroup analysis 61 PENTASA 61 NPH insulin 61 peginterferon alfa 2a Pegasys 61 transaminase elevations 61 renal artery stenting 61 thromboembolic 61 HORIZONS AMI trial 61 invasive aspergillosis 61 Carotid Stent System 61 thrombolytics 61 pain palliation 61 SilverHawk Plaque Excision System 61 BROVANA 61 alvimopan 60 ICD therapy 60 poor metabolizers 60 VELCADE melphalan 60 rosuvastatin Crestor 60 GAMMAGARD LIQUID 60 coadministration 60 Meets Primary Endpoint 60 Patients Treated 60 ADHF 60 antiplatelet therapy 60 NYHA Class III 60 tacrolimus ointment 60 serum phosphate levels 60 multicentre randomized 60 PFO closure 60 flutamide 60 aspirin heparin 60 Novartis Diovan 60 insulin detemir 60 docetaxel chemotherapy 60 restenosis 60 ORENCIA R 60 Fluid Status 60 peripheral stent 60 FRAGMIN 60 Hepsera 60 Surgical Mesh 60 Vaprisol 60 TAVR 60 GEM OS1 60 R lenalidomide 60 doripenem 60 antiepileptic drug 60 oral antidiabetic 60 Taxus Liberte stent 60 eculizumab therapy 60 mg QD 60 COPEGUS 60 STEMI ST 60 Bevacizumab 60 PEG IFN 60 #mg QD [002] 60 Capecitabine 60 Zemplar 60 TM Embolic Protection 60 Lialda 60 Taxus 60 Acute Coronary Syndrome 60 biphasic insulin aspart 60 HeartMate ® 60 Irinotecan 60 Heartmate 60 enoxaparin 60 PNH patients 60 inhaled iloprost 60 dose cohort 60 DUROS 60 liposomal formulation 60 Medtronic CoreValve ® 60 Xience 60 fenofibrate 60 Gemzar ® 60 somatostatin analogues 60 RRMS patients 60 UA NSTEMI 60 canakinumab 60 locoregional recurrence 60 DexaSite 60 PressureWire 60 bypass graft CABG surgery 60 Enoxaparin 60 angiotensin II receptor blocker 60 TAVI 60 bivalirudin monotherapy 60 Aclasta 60 AEGR 60 multicenter multinational 60 Vascugel ® 60 sargramostim 60 PREZISTA r 60 Cipralex ® 60 ToGA 60 SpideRX 60 ACUITY trial 60 resynchronization therapy 60 EXPAREL 60 serum calcium levels 60 inotropic therapy 60 PROCRIT 60 COMBIVIR 60 MGuard ™ 60 Humalog ® 60 esomeprazole Nexium 60 Durezol 60 edoxaban 60 XIENCE V vs. 60 Export Aspiration Catheter 60 AGGRASTAT R 60 PRECISE 60 Zorbtive TM 60 Express2 TM Paclitaxel Eluting 60 Zarnestra 60 TNF antagonist 60 nonfatal MI 60 APOPTONE 60 TYGACIL 60 MULTAQ 60 hematological parameters 60 BRIM2 60 pantoprazole 60 EURIDIS 60 bovine thrombin 60 MoxDuo TM IR 60 ACCULINK 60 ACR# responses 60 everolimus 60 receiving VICTRELIS 60 AGILECT R 60 TAXUS Express2 paclitaxel eluting 60 Intravitreal 60 CIPN 60 EDSS scores 60 Focalin XR 60 Combo Stent 60 fully bioabsorbable 60 TEAEs 60 HbA 1c levels 60 lopinavir r arm 60 SUPPRELIN R LA 60 docetaxel Taxotere 60 dexmedetomidine 60 LV dysfunction 60 ALGRX 60 levetiracetam Keppra 60 MYDICAR ® 60 Coversyl 60 thrombectomy 60 Median PFS 60 locoregional disease 60 CD HORIZON 60 novel oral anticoagulant 60 metaglidasen 60 CTAP# Capsules 60 Torisel 60 plasma renin activity 60 Arixtra ® 60 Peginterferon 60 Velcade bortezomib 60 R# #mg BID 60 Tekturna HCT 60 MYLOTARG 60 unfractionated heparin 60 ePTFE graft 60 GORE TAG 60 CABG surgery 60 MACUGEN 60 vandetanib 60 Pivotal Phase 60 Sanofi Aventis Taxotere 60 LMWH 60 Azedra 60 revascularization 60 ThromCat 60 PrandiMet 60 Noxafil 60 haloperidol Haldol 60 acute PAO 60 XIENCE PRIME TM 60 Taxol paclitaxel 60 TURBO Booster 60 paroxetine Paxil 60 stable angina 60 Dacogen decitabine 60 Teriparatide 60 oral allopurinol 60 Mycamine 60 LIVALO 60 symptomatic intracranial hemorrhage 60 evaluable subjects 60 graft patency 60 LPV r 60 carotid artery stent 60 renarrowing 60 COGNIS 60 MADIT CRT 60 esomeprazole 60 Tarceva TM 60 angiotensin converting enzyme inhibitor 60 hemoglobin A1c levels 60 Ranolazine 60 Eculizumab 60 biventricular pacing 60 Ventavis 60 ischaemia 60 pharmacokinetic PK profile 60 intima media thickness 60 glomerular filtration 60 Infarct 60 CoFactor 60 coronary revascularization 60 #mg BID [002] 60 Zyclara 60 Aortic Stenosis 60 TNF Tumor Necrosis Factor 60 TEMODAL 60 atrasentan 60 Abbott HUMIRA 60 WallFlex Biliary RX 60 neoadjuvant 60 CLARITY study 60 Biolimus A9 60 mRCC 60 ENDEAVOR clinical 60 BARACLUDE R 60 Adhibit 60 Nesiritide 60 achieved PASI 60 endometrial hyperplasia 60 Zocor simvastatin 60 COREG 60 Taxotere ® 60 workhorse lesions 60 CYT# potent vascular disrupting 60 Edwards SAPIEN valve 60 Keppra R 60 eculizumab 60 Aflibercept 60 Anticoagulation 60 benazepril 60 caspofungin 60 seropositive patients 60 graft occlusion 60 Dynesys 60 EOquin TM 60 secondary endpoint 60 angiotensin converting enzyme inhibitors 60 TELCYTA

Back to home page